CompuGroup Medical Acquires VISUS Health IT

CompuGroup Medical SECompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany.

VISUS's key products are JiveX Enterprise PACS, a leading PACS for hospitals and outpatient facilities, JiveX Healthcare Content Management, a cutting-edge vendor neutral archive solution for medical data, and JiveX Healthcare Connect with focus on communicating medical data. As a result of the acquisition, CompuGroup Medical is complementing its portfolio with a well-established and multiple award-winning product suite. For 2020, revenues were amounted to approximately EUR 18.5 million with an adjusted EBITDA of approximately EUR 2.8 million.

"VISUS complements our existing portfolio of products perfectly and we see a lot of opportunities to integrate these solutions with our successful ambulatory and hospital information systems," emphasized Dr. Dirk Wössner, CEO of CompuGroup Medical SE & Co. KGaA. "We are confident that both, existing CGM and VISUS customers, will benefit from this transaction, facilitating the provision of structured medical data at the right place and time and usable by anyone who needs it. VISUS solutions are a key contributor of medical information with the special focus on medical images."

"With this acquisition, we will gain an additional, highly attractive business area, which is very important for most of our customers, and we will significantly increase our installed customer base particularly in the German hospital market. At the same time, we will benefit from a great amount of know-how and expert knowledge from our new colleagues. We are acquiring innovative and strongly growing products here, which have recently been repeatedly honored with several highly prestigious 'Best in KLAS-Awards'," said Hannes Reichl, Managing Director Inpatient and Social Care at CGM.

"We are convinced that with this merger we will continue the success story of VISUS for our team and our customers in the long term. With CGM, we also have the potential to further expand our existing partner network internationally," said Klaus Kleber, Co-Founder of VISUS. Jörg Holstein, likewise Co-Founder of VISUS, added, "We have been partners with CGM for many years and have implemented many successful projects together. We are pleased to become part of the CGM family while maintaining the VISUS identity. CGM is exactly the right partner for us as a global player with home and heart in Germany."

VISUS's customer base today consists of more than 1.500 facilities inpatient as well as outpatient. Today, more than 1.6 million professional users, including doctors, dentists, pharmacies and other health professionals in outpatient and inpatient healthcare facilities trust CompuGroup Medical.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...